My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

DCM Financial Services to hold board meeting
Oct 21,2016

DCM Financial Services will hold a meeting of the Board of Directors of the Company on 28 October 2016, to consider the holding of AGM for the year 2016.

Powered by Capital Market - Live News

Omax Autos to hold board meeting
Oct 21,2016

Omax Autos will hold a meeting of the Board of Directors of the Company on 27 October 2016, to consider the Unaudited Financial Results of the Company for the quarter and half year ended 30 September 2016.

Powered by Capital Market - Live News

Arman Financial Services to hold board meeting
Oct 21,2016

Arman Financial Services will hold a meeting of the Board of Directors of the Company on 14 November 2016, to consider & approve the Unaudited Financial Results (Both Standalone & Consolidated) for the Quarter / Half Year ended on 30 September 2016.

Powered by Capital Market - Live News

RLF to hold board meeting
Oct 21,2016

RLF will hold a meeting of the Board of Directors of the Company on 4 November 2016, to consider the standalone & consolidated unaudited financial results for the quarter and half year ended 30 September 2016.

Powered by Capital Market - Live News

Sumedha Fiscal Services to hold board meeting
Oct 21,2016

Sumedha Fiscal Services will hold a meeting of the Board of Directors of the Company on 5 November 2016, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended 30 September 2016.

Powered by Capital Market - Live News

The Hi-Tech Gears to hold board meeting
Oct 21,2016

The Hi-Tech Gears will hold a meeting of the Board of Directors of the Company on 28 October 2016, to consider Approve and take on record the quarterly un-audited financial results for the 2nd quarter & half year ended on 30 September 2016 & To consider and appoint Chief Financial Officer (CFO) of the Company.

Powered by Capital Market - Live News

Revathi Equipment to hold board meeting
Oct 21,2016

Revathi Equipment will hold a meeting of the Board of Directors of the Company on 7 November 2016, to consider and approve the un-audited Financial Results for the quarter period/half year ended 30 September 2016.

Powered by Capital Market - Live News

Chartered Capital & Investment to hold board meeting
Oct 21,2016

Chartered Capital & Investment will hold a meeting of the Board of Directors of the Company on 28 October 2016, to consider and approve Unaudited Financial Results of the company for the quarter and period ended 30 September 2016.

Powered by Capital Market - Live News

Rich Universe Network to hold board meeting
Oct 21,2016

Rich Universe Network will hold a meeting of the Board of Directors of the Company on 7 November 2016, to consider & approve the un-audited financial results for the quarter ended 30 September 2016.

Powered by Capital Market - Live News

Welspun India to hold board meeting
Oct 21,2016

Welspun India will hold a meeting of the Board of Directors of the Company on 14 November 2016, to consider and take on record, unaudited financial results for the quarter ended on 30 September 2016.

Powered by Capital Market - Live News

Rolcon Engineering Company to hold board meeting
Oct 21,2016

Rolcon Engineering Company will hold a meeting of the Board of Directors of the Company on 8 November 2016, to consider and approve the Unaudited financial Result of the Company for the quarter ended on 30 September 2016.

Powered by Capital Market - Live News

Ind-Agiv Commerce to hold board meeting
Oct 21,2016

Ind-Agiv Commerce will hold a meeting of the Board of Directors of the Company on 28 October 2016, to Consider and take on record the Unaudited financial results for the half year ended on 30 September 2016.

Powered by Capital Market - Live News

Gujarat Ambuja Exports to hold board meeting
Oct 21,2016

Gujarat Ambuja Exports will hold a meeting of the Board of Directors of the Company on 12 November 2016, to consider and approve Unaudited Financial Results of the Company for the second quarter and half year ended 30 September 2016 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Powered by Capital Market - Live News

Syngene International hits record high after posting robust Q2 results
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 135.11 points, or 0.49%, to 27,990.72.

High volumes were witnessed on the counter. On BSE, so far 65,911 shares were traded in the counter, compared with average daily volume of 31,445 shares in the past one quarter. The stock hit a high of Rs 565 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 546.05 so far during the day. The stock hit a 52-week low of Rs 343.70 on 9 November 2015. The stock had outperformed the market over the past one month till 20 October 2016, rising 14.88% compared with 1.38% decline in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 28.49% as against Sensexs 0.77% rise.

The mid-cap company has equity capital of Rs 200 crore. Face value per share is Rs 10.

Syngene Internationals earnings before interest, taxes, depreciation and amortization (EBITDA) rose 49% to Rs 122 crore in Q2 September 2016 over Q2 September 2015. EBITDA margin rose to 38% in Q2 September 2016 from 31% in Q2 September 2015.

Promoted by Biocon, Syngene International is a leading India-based contract research organization (CRO) offering a suite of integrated and end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors. Biocon holds 72.61% stake in Syngene, as per the shareholding pattern as on 30 September 2016.

Powered by Capital Market - Live News

Biocon scales record high after turnaround Q2 outcome
Oct 21,2016

The result was announced after market hours yesterday, 20 October 2016.

Meanwhile, the S&P BSE Sensex was down 138 points or 0.49% at 27,991.84

On BSE, so far 2.23 lakh shares were traded in the counter as against average daily volume of 1.67 lakh shares in the past one quarter. The stock hit a high of Rs 1,020 so far during the day, which is also a record high for the stock. The stock hit a low of Rs 978 so far during the day. The stock had hit a 52-week low of Rs 430.80 on 12 February 2016. The stock had outperformed the market over the past 30 days till 20 October 2016, gaining 3.48% compared with 1.32% fall in the Sensex. The scrip also outperformed the market in past one quarter, advancing 21.21% as against Sensexs 1.17% rise.

The large-cap company has equity capital of Rs 100 crore. Face value per share is Rs 5.

Biocons consolidated total income rose 21.2% to Rs 992.50 crore in Q2 September 2016 over Q2 September 2015. Consolidated earnings before interest, taxation, depreciation and amortization (EBITDA) rose 45% to Rs 277 crore in Q2 September 2016 over Q2 September 2015. EBITDA margin improved to 28% in Q2 September 2016 from 23% in Q2 September 2015.

Biocon said that the company reported robust performance led by a strong growth of Small Molecules, Biologics and Syngene. Licensing income stood at Rs 32 crore while other income reported was Rs 52 crore in Q2 September 2016.

Commenting on the quarterly performance and highlights, Chairperson and Managing Director, Kiran Mazumdar-Shaw stated that the companys performance in Q2 September 2016, was led by strong growth across small molecules, biologics and research services. Expansion of biologics footprint in emerging markets and licensing agreements boosted the revenue further. The companys ready-to-use Insulin Glargine pen launched in Japan has been well received which augurs well for business. The acceptance of proposed biosimilar Trastuzumab filing for review by EMA was a critical milestone in Q2 September 2016. She added that long term investments in R&D, manufacturing facility in Malaysia and clinical advancement of programs will enable the company to unlock greater value, going forward.

Biocon is Indias largest and fully-integrated, innovation-led biopharmaceutical company.

Powered by Capital Market - Live News